21金维他品牌怎么样 申请店铺

我要投票 21金维他在补铁锌硒行业中的票数:752 更新时间:2025-04-27
21金维他是哪个国家的品牌?「21金维他」是杭州赛诺菲民生健康药业有限公司旗下著名品牌。该品牌发源于浙江,由创始人张海敏在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力21金维他品牌出海!通过在本页面挂载21金维他品牌的产品链接和联系方式,可以提高21金维他产品曝光!跨境电商爆单神器,目前只要100元/年哦~

21金维他怎么样

21金维他,1984年上市,是中国率先上市的多维元素产品。根据中国人营养状况和饮食习惯科学配比,均衡补充人体所需的21维生素和矿物质,采用国际一流生产线生产的健康产品。

“21金维他”是一种主要原料由21种维生素和微量元素组成的药品,是一种高级的维生素补充剂。21金维他里面含有维生素C和E,维生素C可以美白,增强抵抗力,抗衰老,维生素E有软化血管,抗衰老,美白,可以用于美容,祛除一定的斑痕。

杭州民生药业有限公司创建于1926年,是中国最早的四大西药厂之一。80余年来,民生药业一直专注于西药制药产业,见证了中国整个西药制药的历史。2006年被商务部评为第一批“中华老字号”企业。

公司主要生产处方药(抗肿瘤药、抗乙肝、心血管类)、OTC(含维生素和保健品类)、大输液(包括特种输液)以及原料药等四大品类的品种。21金维他在2004年被认定为“中国驰名商标”,并确立了在国内多维元素补充剂市场的领军品牌地位。另外公司在抗肿瘤及大输液等领域享有较高的市场声誉。

公司具有较强的产品开发能力和先进的质量保证体系。粉针剂、冻干粉针剂、大容量注射剂和片剂已获药品GMP证书。同时公司被杭州市政府有关部门确定为高效化学原料及各类新型制剂的研究和生产基地的高新技术企业。

80余年的积累和发展,民生药业成为了一家专业化、负责任的现代化制药公司,公司在2002年至2006年间成功实施了跳跃式发展战略;从2007年开始全面实施的国际化发展战略,将引领企业走向新的辉煌。打造一个经久不衰、生生不息、充满青春活力的百年民生是我们的追求!

杭州赛诺菲民生健康药业有限公司成立于2010年,是由全球领先的多元化医药健康企业赛诺菲与杭州民生药业集团共同组建的健康药业领域合资企业。这标志着赛诺菲正式进军充满活力的中国非处方药市场,同时也是全球第二大的非处方药市场。

作为全球领先的多元化医药健康企业,赛诺菲在健康药业领域通过不断并购,扩大其在全球的实力。进入中国健康药业市场成为赛诺菲支持中国预防保健事业的又一支柱。赛诺菲与长期合作的伙伴民生药业成立合资企业,旨在使21金维他®等品牌覆盖到各个市场,让更多的中国百姓享受到健康保障。

Kingvita, launched in 1984, is the first multi-dimensional element product to be launched in China. According to the scientific proportion of Chinese Nutrition and diet habits, we should supplement the 21 vitamins and minerals needed by human body in a balanced way, and adopt the health products produced by the world-class production line. "21 jinvita" is a kind of medicine composed of 21 kinds of vitamins and microelements, which is a kind of advanced vitamin supplement. Jinvita contains vitamin C and E. vitamin C can whiten, enhance resistance and resist aging. Vitamin E can soften blood vessels, resist aging and whiten. It can be used for beauty and remove certain spots. Founded in 1926, Hangzhou Minsheng Pharmaceutical Co., Ltd. is one of the first four Western pharmaceutical factories in China. For more than 80 years, Minsheng pharmaceutical industry has been focusing on Western pharmaceutical industry, witnessing the history of the whole western pharmaceutical industry in China. In 2006, it was awarded the first batch of "Chinese time-honored brand" enterprises by the Ministry of Commerce. The company mainly produces prescription drugs (anti-tumor drugs, anti hepatitis B drugs, cardiovascular drugs), OTC (including vitamins and health care products), large infusion (including special infusion) and APIs. In 2004, kingvita was recognized as "China's well-known trademark" and established its leading brand position in the domestic multi-dimensional element supplement market. In addition, the company enjoys a high market reputation in the fields of anti-tumor and infusion. The company has strong product development ability and advanced quality assurance system. Powder injection, freeze-dried powder injection, large volume injection and tablet have obtained GMP certificate. At the same time, the company is determined by the relevant departments of Hangzhou municipal government as a high-tech enterprise in the research and production base of high-efficiency chemical raw materials and various new preparations. With more than 80 years of accumulation and development, Minsheng pharmaceutical industry has become a professional and responsible modern pharmaceutical company. From 2002 to 2006, Minsheng pharmaceutical successfully implemented the leaping development strategy. The international development strategy, which has been fully implemented since 2007, will lead the enterprise to a new glory. It is our pursuit to build a centenary people's livelihood that is enduring, endless and full of youth and vitality! Hangzhou Sanofi Minsheng Health Pharmaceutical Co., Ltd., founded in 2010, is a joint venture in the field of health pharmaceutical jointly established by Sanofi, a global leading diversified pharmaceutical and health enterprise, and Hangzhou Minsheng Pharmaceutical Group. This marks Sanofi's official entry into the dynamic Chinese over-the-counter drug market, which is also the second largest over-the-counter drug market in the world. As a leading diversified medical and health enterprise in the world, Sanofi expands its global strength through continuous M & A in the field of health medicine. Entering the Chinese health pharmaceutical market has become another pillar of Sanofi's support for China's prevention and health care. Sanofi has set up a joint venture with Minsheng pharmaceutical, a long-term partner, aiming to make 21 jinvita ® and other brands reach all markets and more Chinese people enjoy health protection.

本文链接: https://brand.waitui.com/0d30c126b.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

大农科技股份有限公司完成1000万元天使轮融资

36氪获悉,近日,大农科技股份有限公司宣布完成1000万元天使轮融资。此次融资由某投资机构领投。大农科技表示此轮资金将用于赋能五大核心业务:智慧供应链管理方面,优化配送系统,提升配送效率;数字化团餐服务方面,拓展社区团购与预包装食品业务;科技农业创新方面,加大智慧农场建设投入,完善农产品追溯体系;低空物流探索中,加速无人机配送技术研发;社区生鲜连锁品牌方面,完善门店布局,提升服务品质。

2小时前

迪阿股份:2024年营收14.8亿元,经营性现金流同比增长755%

36氪获悉,迪阿股份发布2024年度业绩报告。2024年实现营业收入14.8亿元,其中线上自建平台营业收入同比增长超80%;经营性现金流净额3.2亿元,同比增长755%,2024年年末公司在手现金及现金等价物、理财产品约62.11亿元。截至2024年底,公司终端自营门店373家,覆盖近200个城市。

2小时前

夸克AI超级框上新“拍照问夸克”,加码多模态能力

4月27日,夸克AI超级框发布全新AI相机,上新“拍照问夸克”功能。基于视觉理解与思考推理的强大模型能力,夸克AI超级框从视觉出发创新下一代搜索体验,进一步理解和回答物理世界中的各类问题。目前,夸克具备超百个专业Agent和原子能力,包括搜索、健康、学习、旅游、商品、创作等。作为阿里巴巴AI旗舰应用,夸克AI超级框持续快速迭代,提升超级智能体的多模态能力,打造用户生活、工作、学习的AI超级入口。

2小时前

万事网联展业近一年,新发行和升级百余款“中国万事达”银行卡

36氪获悉,至今年5月9日,万事网联开业即将满一周年。近一年来,在保持清算系统稳健运行的基础上,万事网联已与21家银行合作,新发行和升级百余款境内境外、线上线下通用的全新“中国万事达”银行卡产品和配套特色权益。同时,万事网联与各银行和支付机构共同发力,持续推动线上、线下受理网络的拓展和完善。除了常见的大小额消费场景外,还突破性地实现了万事达卡在北京地铁轨道交通中的拍卡过闸功能。

2小时前

OceanBase任命CTO杨传辉担任AI战略一号位

36氪获悉,今日OceanBaseq发布全员信,宣布OceanBase将全面进入AI时代,打造“DATA×AI”核心能力,建设AI时代的数据底座。为保障战略推进,OceanBase启动人才和组织体系升级,任命CTO杨传辉担任AI战略一号位,并成立AI平台与应用部、AI引擎组等新部门。

2小时前

本页详细列出关于21金维他的品牌信息,含品牌所属公司介绍,21金维他所处行业的品牌地位及优势。
咨询